Indivior Gift to Support MOUD in Jails and Prisons

The NCCHC Foundation is pleased to announce Indivior’s Platinum Level support for the Foundation’s Partners in Correctional Health Annual Giving Society. The global pharmaceutical company will be the first to participate at this level.

At the highest partnership level, Indivior’s financial support will contribute to the mission of the NCCHC Foundation: to champion the correctional health care field and serve the public by supporting research, professional education, scholarships, and patient reentry into the community.

Indivior manufactures and markets medicines for the treatment of moderate to severe opioid use disorder (OUD), increasingly recognized as a critical component of addressing the national opioid crisis.

“Scientific evidence has firmly established that substance use disorders represent a chronic, relapsing disease requiring effective treatment. Medication for opioid use disorder – MOUD – is the national medical standard,” says Jennifer Riskind, NCCHC Foundation director.

NCCHC has long been an advocate for MOUD in correctional settings, where individuals with opioid use disorder are overrepresented. The Bureau of Justice Statistics found that two-thirds of the sentenced jail population and more than half of the state prison population met the criteria for drug dependence or abuse, compared to just 5% of the adult general population.

“Indivior is proud to support the work of the NCCHC Foundation and its mission to improve patient care in federal, state and local correctional facilities,” said Mark Crossley, chief executive officer, Indivior. “Our nation’s justice system has been significantly affected by the opioid crisis, with an estimated 17 percent of state prison inmates and 19 percent of jail inmates reporting regularly using opioids. Indivior is committed to supporting initiatives and programs that help tackle the unique challenges facing people in these settings, including helping increase access to evidence-based treatments.”

The majority of incarcerated individuals – up to 96% of people in jail – will return to their communities. Studies overwhelmingly associate access to MOUD with positive postrelease outcomes: reductions in mortality, illicit substance use, crime, recidivism, and health problems like HIV and HCV due to reductions in needle sharing.

“Annual leadership gifts like Indivior’s ensure an ongoing foundation of support to help move the field of correctional health care forward,” says Riskind. “Their gift helps demonstrate the importance of corporate leadership and recognizes the vital connection between correctional health and public health.”

Founded in 2020, the NCCHC Foundation is the philanthropic charitable arm of the National Commission on Correctional Health Care, the only national organization dedicated to improving the quality of health care in the nation’s jails, prisons, and juvenile facilities.